Biosimilar Medicines: a Game Changer for Oncology Care

23 March 2017

With 10 years of positive experience with biosimilar medicines, medical […]

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]

European Experience and Evidence of Physician-led Switching of Biological Medicines Give Hope to Patients around the World

14 March 2017

On 9th March, IFPMA launched jointly with EFPIA and EBE […]

Experience and Evidence of Physician-led Switching of Biological Medicines Fully Recognised in Europe

9 March 2017

Medicines for Europe welcomes the fact that EFPIA (supported by […]

European Parliament Recognises the Major role of Generic, Biosimilar and Value Added Medicines in Improving Access

2 March 2017

Today, the European Parliament voted on the report on ‘Options […]

Joint Declaration for an ambitious EU industrial strategy

27 February 2017

Europe is the cradle of the manufacturing industry and has […]

EU-Canada Free Trade Agreement: an Opportunity to Create Manufacturing Jobs in the Generic and Biosimilar Medicines Industries

20 February 2017

Medicines for Europe welcomes the approval by the European Parliament […]

Health Minister Can Take Action to Increase Patient Access to Biosimilar Medicines in Ireland

8 February 2017

Today, Medicines for Europe engaged alongside its Irish national association […]

Joint statement on Shortages

2 February 2017

The European associations representing manufacturers of medicinal products, parallel distributors, […]

European Parliament prioritises Generic, Biosimilar and Value Added Medicines Competition to improve Access

31 January 2017

Today, the Environment, Public Health and Food Safety Committee (ENVI) voted […]

Newsroom

News about

By type

Twitter

Videos

Photos

Biosimilar Medicines: a Game Changer for Oncology Care

23 March 2017

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

European Experience and Evidence of Physician-led Switching of Biological Medicines Give Hope to Patients around the World

14 March 2017

Experience and Evidence of Physician-led Switching of Biological Medicines Fully Recognised in Europe

9 March 2017

European Parliament Recognises the Major role of Generic, Biosimilar and Value Added Medicines in Improving Access

2 March 2017

Joint Declaration for an ambitious EU industrial strategy

27 February 2017

EU-Canada Free Trade Agreement: an Opportunity to Create Manufacturing Jobs in the Generic and Biosimilar Medicines Industries

20 February 2017

Health Minister Can Take Action to Increase Patient Access to Biosimilar Medicines in Ireland

8 February 2017

Joint statement on Shortages

2 February 2017

European Parliament prioritises Generic, Biosimilar and Value Added Medicines Competition to improve Access

31 January 2017

Subscribe to our newsletter